M
$ Value
—
Shares
8,013
Price
—
Filed
Jun 2
Insider
Name
Lurker Nancy
Title
—
CIK
0001450485
Roles
Director
Transaction Details
Transaction Date
2025-05-31
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
Each restricted stock unit represents a contingent right to receive one ordinary share. | This award is fully vested in accordance with its terms.
Filing Info
Lurker Nancy's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-11 | ALKS | M | — |
| 2026-04-11 | ALKS | F | $30K |
| 2026-04-11 | ALKS | M | — |
| 2025-12-04 | EYPT | ▼ | $140K |
| 2025-11-28 | EYPT | ▼ | $7K |
| 2025-11-26 | EYPT | ▼ | $3K |
| 2025-07-10 | EYPT | M | $0 |
| 2025-07-10 | EYPT | M | $0 |
| 2025-07-02 | EYPT | G | $0 |
| 2025-07-02 | EYPT | G | $0 |
Other Insiders at ALKS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Lurker Nancy | — | — | 2026-04-11 |
|
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
|
— | $70K | 2026-04-06 |
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
|
— | $320K | 2026-04-01 |